We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Understanding P-gp and BCRP Inhibition Assay Design and Outcomes

Video   Jan 07, 2019

 

Webinar Originally Aired: 12/11/2018 8:00:00 AM
Presenter: Andrea Wolff, Sekisui XenoTech Director of Services Logistics
Synopsis: In vitro drug transporter inhibition studies are recognized for their importance due to the major role transporters play in absorption, distribution and excretion of compounds, and the toxicological and pharmacological consequences of transporter-mediated drug-drug interactions (DDI). P-gp and BCRP transporters limit intestinal absorption and blood-brain barrier penetration, and facilitate excretion into bile and urine. Andrea Wolff, Sekisui XenoTech Director of Services Logistics, recently provided a webinar to the SimCyp transporter discussion group on P-gp and BCRP Inhibition. For those who did not have the opportunity to hear her presentation, we are hosted a follow-up webinar on Dec. 11th. Key concepts discussed in this webinar will include: - Description of the in vitro test systems used to evaluate P-gp and - BCRP inhibition at Sekisui XenoTech and the advantages/disadvantages of these assays - Description of the test system qualification process that takes places prior to offering these assays in definitive studies - Comparison of IC50 values obtained from the different test systems - Comparison of IC50 and Ki values determined with the vesicle test system - How IC50 and Ki values are used to evaluate clinical relevance Download a copy of the slides: https://www.xenotech.com/webinars/webinar-registration-pgp-bcrp-inhibition
Questions, comments and requests: https://www.xenotech.com/contact-us
More information on our transporter services: https://www.xenotech.com/services/drug-transporters
Other previously aired webinars: https://www.xenotech.com/scientific-resources/webinar-series
Upcoming webinars: https://www.xenotech.com/scientific-resources/webinar-series/request-a-webinar

 
More Information
 
 
Advertisement
 

Recommended Videos

SARS-CoV-2 Infected Host Cell Proteomics Reveal Potential Therapy Targets

Video

As part of the London Proteomics Discussion Group webinar series: "SARS-CoV-2: What role can proteomics play?" Dr Münch presented his work on changes in response to SARS-CoV-2 infection, highlighting potential therapies.

WATCH NOW

The Coronavirus Outbreak Explained Through 3D Medical Animation

Video

This 3D medical animation explains what a pandemic is, rates of infection and ways to protect against infections. It also delves into the biology and mechanism of action (MoA) that coronavirus uses to infect and destroy human cells. Though the exact MoA for this coronavirus is not known.

WATCH NOW

Why Blue Whales Don't Get Cancer – Peto's Paradox

Video

Cancer is a creepy and mysterious thing. While we tried to understand it, to get better at killing it, we discovered a biological paradox that remains unsolved to this day: large animals seem to be immune to cancer. Which doesn’t make any sense – the bigger a being, the more cancer it should have. To understand why, we first need to take a look at the nature of cancer itself.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE